Catherine Burton

483 total citations
29 papers, 357 citations indexed

About

Catherine Burton is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Catherine Burton has authored 29 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 12 papers in Immunology and 11 papers in Infectious Diseases. Recurrent topics in Catherine Burton's work include HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (8 papers). Catherine Burton is often cited by papers focused on HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (8 papers). Catherine Burton collaborates with scholars based in United Kingdom, United States and Australia. Catherine Burton's co-authors include Nesrina Imami, Frances Gotch, Brian Gazzard, Mark Nelson, Alan Steel, Gareth Hardy, António Pires, Christopher M. Mela, F Gotch and Martin R. Goodier and has published in prestigious journals such as The Journal of Immunology, European Journal of Cancer and AIDS.

In The Last Decade

Catherine Burton

28 papers receiving 352 citations

Peers

Countries citing papers authored by Catherine Burton

Since Specialization

Citations

This map shows the geographic impact of Catherine Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Burton more than expected).

Fields of papers citing papers by Catherine Burton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Burton. The network helps show where Catherine Burton may publish in the future.

Co-authorship network of co-authors of Catherine Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Burton. A scholar is included among the top collaborators of Catherine Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Burton. Catherine Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	What really matters in cancer? 2013 ·European Journal of Cancer ·Arnie Purushotham, Jocelyn Cornwell, Catherine Burton, Derek Stewart, Richard Sullivan	2
2	Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization 2008 ·Vaccine ·Lindvi Gudmundsdotter, (unknown), Catherine Burton, Guglielmo Rosignoli, Eric Sandström, Bo Hejdeman, Britta Wahrén, Nesrina Imami, Frances Gotch	4
3	Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy 2008 ·Clinical & Experimental Immunology ·Catherine Burton, Ruth Goodall, Assia Samri, Brigitte Autran, Anthony D. Kelleher, Guido Poli, Giuseppe Pantaleo, F Gotch, Nesrina Imami	15
4	Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients 2007 ·AIDS ·Guglielmo Rosignoli, Alison Cranage, Catherine Burton, Mark Nelson, Alan Steel, Brian Gazzard, Frances Gotch, Nesrina Imami	24
5	Three-Year Immune Reconstitution in PI-Sparing and PI-Containing Antiretroviral Regimens in Advanced HIV-1 Disease 2007 ·Antiviral Therapy ·Assia Samri, Ruth Goodall, Catherine Burton, Nesrina Imami, Giuseppe Pantaleo, Anthony D. Kelleher, Guido Poli, Frances Gotch, Brigitte Autran	6
6	Combined Use of Cytokines, Hormones and Therapeutic Vaccines During Effective Antiretroviral Therapy 2007 ·Nesrina Imami, Samantha J. Westrop, Alison Cranage, Catherine Burton, Frances Gotch	9
7	Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy 2005 ·AIDS ·Christopher M. Mela, Catherine Burton, Nesrina Imami, Mark Nelson, Alan Steel, Brian Gazzard, Frances Gotch, Martin R. Goodier	75
8	Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: Concomitant assessment of perforin, IFN-γ and IL-4 secretion 2005 ·Journal of Immunological Methods ·Catherine Burton, Frances Gotch, Nesrina Imami	13
9	The challenge of developing an effective HIV-1 vaccine 2004 ·Drug Discovery Today Therapeutic Strategies ·Nesrina Imami, António Pires, Catherine Burton	1
10	Restoration of Human Immunodeficiency Virus‐1‐Specific Responses in Patients Changing from Protease to Non‐Nucleoside Reverse Transcriptase Inhibitor‐Based Antiretroviral Therapy 2003 ·Scandinavian Journal of Immunology ·Ann Sullivan, Catherine Burton, Mark Nelson, Graeme Moyle, Sundhiya Mandalia, F Gotch, Brian Gazzard, Nesrina Imami	6
11	Thymic Output during Initial Highly Active Antiretroviral Therapy (HAART) and during HAART Supplementation with Interleukin 2 and/or with HIV Type 1 Immunogen (Remune) 2003 ·AIDS Research and Human Retroviruses ·Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, António Pires, Ann Sullivan, Brian Gazzard, Richard Aspinall, Frances Gotch, Nesrina Imami	13
12	Oxidative haemolysis secondary to high‐dose vitamins in a woman with glucose‐6‐phosphate dehydrogenase deficiency 2003 ·British Journal of Haematology ·Catherine Burton, Richard Kaczmarski	2
13	Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness 2003 ·Clinical & Experimental Immunology ·Gareth Hardy, Nesrina Imami, Ann Sullivan, António Pires, Catherine Burton, Mark Nelson, Brian Gazzard, F Gotch	29
14	The Exon A (C77G) Mutation Is a Common Cause of Abnormal CD45 Splicing in Humans 2001 ·The Journal of Immunology ·Elma Tchilian, Diana L. Wallace, Nesrina Imami, Hua‐Xin Liao, Catherine Burton, Frances Gotch, Jeremy Martinson, Barton F. Haynes, Peter C. L. Beverley	17
15	Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination 2001 ·Immunology Letters ·Nesrina Imami, Gareth Hardy, Catherine Burton, António Pires, Jeffrey Pido-Lopez, (unknown), B Gazzard, F Gotch	31
16	Detection and quantification of HIV‐1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV‐1‐infected individuals and vaccine recipients 2001 ·HIV Medicine ·Nesrina Imami, Gareth Hardy, António Pires, Catherine Burton, Ann Sullivan, F Gotch	4
17	A point mutation in CD45 may be associated with an increased risk of HIV-1 infection 2001 ·AIDS ·Elma Tchilian, Diana L. Wallace, (unknown), Nesrina Imami, Catherine Burton, Frances Gotch, Peter C. L. Beverley	43
18	Verification and transformation of simple recursive programs-an algebraic approach 1991 ·Clarendon Press eBooks ·Catherine Burton	1
19	Specifying the apple Macintosh ^™ Toolbox event manager 1989 ·Formal Aspects of Computing ·Catherine Burton, Steve Cook, (unknown), (unknown), (unknown)	3
20	On the algebras of symmetries (groups of collineations) of designs from finite Desarguesian planes with applications in statistics 1982 ·Journal of Mathematical Analysis and Applications ·I. M. Chakravarti, Catherine Burton	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact